Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Eql Pharma AB

Closing information (x1000 SEK)

Closing information 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Turnover 373,516 Less Arrow 264,168 Less Arrow 259,913
Financial expenses 13,022 Less Arrow 5,732 Less Arrow 2,372
Earnings before taxes 54,354 Less Arrow 28,604 More Arrow 38,968
EBITDA 80,040 Less Arrow 41,374 More Arrow 49,625
Total assets 808,823 Less Arrow 373,759 Less Arrow 285,696
Current assets 400,252 Less Arrow 197,774 Less Arrow 167,228
Current liabilities 221,018 Less Arrow 162,050 Less Arrow 115,976
Equity capital 221,035 Less Arrow 177,726 Less Arrow 154,753
- share capital 1,308 Equal arrow 1,308 Equal arrow 1,308
Employees (average) 21 Equal arrow 21 Less Arrow 18

Financial ratios

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Solvency 27.3% More Arrow 47.6% More Arrow 54.2%
Turnover per employee 17,786 Less Arrow 12,579 More Arrow 14,440
Profit as a percentage of turnover 14.6% Less Arrow 10.8% More Arrow 15.0%
Return on assets (ROA) 8.3% More Arrow 9.2% More Arrow 14.5%
Current ratio 181.1% Less Arrow 122.0% More Arrow 144.2%
Return on equity (ROE) 24.6% Less Arrow 16.1% More Arrow 25.2%
Change turnover 109,348 Less Arrow 4,255 Less Arrow -149,840
Change turnover % 41% Less Arrow 2% Less Arrow -37%
Chg. No. of employees 0 More Arrow 3 More Arrow 5
Chg. No. of employees % 0% More Arrow 17% More Arrow 38%

Total value of public sale

Fiscal year 2025/03 (consolidated) 2024/03 (consolidated) 2023/03 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.